Anil Kumar Katare

Anil Kumar Katare

Auto-generated profile, based on publicly available information

Anil Kumar Katare

Quality Management and Instrumentation Division, CSIR-Indian Institute of Integrative Medicine, Jammu, India. Academy of Scientific and Innovative Research (AcSIR), Ghaziabad, India

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 August 2020 in Natural Product Research
Verified
Journal Article
Closed access
AKAnil Kumar Katare
Anil Kumar Katare
BSBikarma Singh
Bikarma Singh
PSPooja Shukla
Pooja Shukla
SGSandeep Gupta
Sandeep Gupta
BSBishander Singh
Bishander Singh
RKRahul Kalgotra
Rahul Kalgotra
SARS-CoV-2 (or COVID-19) has become a global risk and scientists are attempting to investigate antiviral vaccine. Berberis are important plants due to the presence of bioactive phytochemicals, especially berberine from the protoberberine group of benzylisoquinoline and recent studies have shown its potential in treating COVID-19. B. lycium Royle growing in subtropical regions of Asia had wide applications in Indian system of medicine. Rapid determination and novel optimisation method for berberine extraction has been developed by Soxhlet extraction utilising central composite design-response surface methodology (CCD-RSM). Berberine was detected by high-performance liquid chromatography (HPLC), and the highest yield (13.39%) was obtained by maintaining optimal extraction conditions i.e., extraction time (7.28 hrs), ethyl alcohol (52.21%) and solvent to sample ratio (21.78 v/w). Investigation of two geographic regions (Ramnagar and Srinagar) showed high berberine content in lower altitude. This novel optimisation technique has placed berberine as a potential candidate for developing pharmaceutical products for human health care.

4 February 2023 in Food Chemistry Advances
Verified
Journal Article
Open access
SSSakshi Sharma
Sakshi Sharma
AKArvind Kumar
Arvind Kumar
SKSunil Kumar
Sunil Kumar
AKAnil K. Katare
Anil K. Katare
HBHina F. Bhat
Hina F. Bhat
ZBZuhaib F. Bhat
Zuhaib F. Bhat

7 November 2023 in Food Chemistry Advances
Verified
Journal Article
Open access
SSSakshi Sharma
Sakshi Sharma
AKArvind Kumar
Arvind Kumar
SKSunil Kumar
Sunil Kumar
AKAnil K. Katare
Anil K. Katare
HBHina F. Bhat
Hina F. Bhat
ZBZuhaib F. Bhat
Zuhaib F. Bhat
The study aimed to develop a functional cheese using Grewia asiatica fruit extract as a novel additive and demonstrated its functional value in oxidative-stress-induced [single dose of CCl4 (1 mL/kg) given intraperitoneally] male Wistar rats. The kalari cheese was developed using buffalo milk containing different levels of the fruit extract (0.0, 0.5, 0.7, and 1.0%) and an optimum level of 0.7% was found sensorily. The products (0.0 and 0.7%) were stored in a refrigerator for 4 weeks and evaluated for storage quality. The extract improved the lipid (TBARS and free-fatty acids) and microbial (total plate and psychrophilic counts) stability and sensory quality of the cheese. The extract-enriched cheese-based diet ameliorated the impact of oxidative stress in the rats during a 4-week feeding trial and significantly (P<0.05) increased the levels of endogenous antioxidant enzymes (superoxide dismutase, glutathione peroxidase and catalase) and body weight whereas significantly (P<0.05) reduced the levels of liver marker enzymes (ALT and AST), lipid peroxidation, and relative liver and spleen weights compared to the control. The extract improved the lipid and microbial stability of the cheese and the cheese-based diet ameliorated the effect of oxidative stress in rats, indicating the functional value of the developed product.

4 July 2025 in International Journal of Environmental Monitoring and Analysis
Verified
Journal Article
Open access
PDF file
AKAnil Katare
Anil Katare
SGSandeep Gupta
Sandeep Gupta
ATAliya Tabassum
Aliya Tabassum
MKManoj Kumar
Manoj Kumar
GDGoutam Dubey
Goutam Dubey
SSSarita Sharma
Sarita Sharma
The pharmaceutical sector manufactures an extensive variety of products by utilizing a combination of organic and inorganic raw materials, which leads to the generation of significant quantities of liquid waste. The concept for evaluation of these critical paramenters comes with the study of literature and burning issues of the environment, especially for pharmaceutical wastewater. This waste is characterized by its toxicity, resistance to biodegradation, and complex organic composition, often accompanied by elevated levels of inorganic total dissolved solids (TDS), chemical oxygen demand (COD), and biochemical oxygen demand (BOD). The pharmaceutical wastewater has a wide spectrum of characteristics in pH, chemical oxygen demand (COD), and biochemical oxygen demand (BOD). The nature of pH is mildly acidic (5.2), COD ranges between 6,000 and 3,000mg/L, and BOD varies from 940 to 900mg/L. This research primarily aims to evaluate the bio-kinetic coefficients by treating pharmaceutical wastewater with an activated sludge process conducted on a pilot plant scale. Due to the novelty in evaluating the bio-kinetics of pharmaceutical wastewater the key could lie in developing an integrated modeling approach that combines real-time microbial activity monitoring to predict degradation rates of complex organic compounds, offering a more precise and dynamic assessment compared to traditional batch kinetic studies. Kmax, Ks, Kd, Y, and μmax were determined to have the following values: 2.09 d -1 , 55.41mg/l, 0.075 d -1 , 0.302g VSS/g COD, and 0.642 d -1 by altering the input variables, i.e., mixed liquor suspended solids (MLSS), retention time, etc. The study was conducted over a three-month time interval, i.e., on a quarterly basis, for the evaluation of bio-kinetic parameters. In the current study, the removal of COD was observed between 92% and 97% with the activated sludge process. The R 2 score ranges from 0.8356 to 0.9270, demonstrating a better fit between the results and the model utilized for the study. Apart from the evaluation of biokinetic studies of pharmaceutical wastewater, the other goals of the current study include producing high-quality effluent and disposing of it without affecting aquatic life or the environment, as well as reducing the pollution load from wastewater generated in the form of hazardous compounds/non-biodegradable substances. We may conclude that the results then obtained for the bio-kinetic parameters are within the acceptable range as per the available literature.